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A B S T R A C T
We analyse eﬀects of parental deaths on the health of women and men aged 18–59 in 2004–2008, indicated by
purchases of prescription medicines. Register data covering the entire Norwegian population were used, and
ﬁxed-eﬀects models were estimated to control for unobserved time-invariant individual factors. A parent's death
seemed to have immediate adverse consequences in both main age groups considered (18–39, 40–59), although
eﬀects were lower in the older group. Some results suggested that this health disadvantage widened with
increasing time since the parent's death. However, eﬀects were weak: the annual number of diﬀerent medicines
purchased was only increased by 1–7% as a result of losing a parent. Death of a parent was associated with an
immediate increase in purchases of medication for mental diseases, and there were indications of a physical
response as well. As time since the parental death increased, there was a decline in the purchase of medication
for mental diseases, but an opposite trend with respect to medication for other diseases. On the whole, maternal
and paternal deaths had the same impact, and eﬀects on daughters and sons were of the same magnitude.
1. Introduction
Relationships with close family members are important in most
people's lives, and disruption of these relationships through death may
have adverse consequences. Half of those who marry and do not
divorce will eventually lose their spouse, and extensive research has
identiﬁed excess mortality (Berntsen & Kravdal, 2012; Shor et al.,
2012) and deteriorating physical (Carey et al., 2014) and mental
(Sasson & Umberson, 2014) health following conjugal bereavement.
However, a loss that an even larger proportion experience – in fact
almost everyone in contemporary rich countries – is parental death.
Obviously, a parent's death may be particularly harmful for young
children, and the consequences of such early parental losses have
attracted considerable scholarly attention (Li et al., 2014), but in
contemporary societies it is far more usual that the death of a parent is
experienced in adulthood. Although adults are clearly less dependent
on their parents than children, strong interpersonal bonds and
exchanges of support are nevertheless common (Attias-Donfut, Ogg,
& Wolﬀ, 2005; Bengtson, 2001; Hank, 2007), and disruption of these
through death of the parent may have adverse eﬀects on the health of
adult oﬀspring.
Results from the few and rather varied studies of adults' responses
to parental bereavement have been mixed. In two American investiga-
tions of short-term responses, the main conclusion was that parental
deaths adversely aﬀected both mental and physical health (Marks, Jun,
& Song, 2007; Umberson & Meichu, 1994), although the opposite
pattern appeared in some groups (Umberson & Meichu, 1994). In
addition to observing a quite immediate eﬀect on health, Marks et al.
(2007) found that both the mental and physical health disadvantage
increased over a ﬁve-year period for those whose parent had already
died when this ﬁve-year period began. However, a Swedish register-
based study focusing on mortality showed relatively low risks shortly
after a parent's death, followed by an increase up to the level in the
remaining population, or even above that among men who had lost
their mother (Rostila & Saarela, 2011). Finally, a recent German study
found that the death of a parent had, on the whole, a rather weak short-
term adverse eﬀect on subjective well-being, but no eﬀect in the longer
term except for daughters who lost their mother early (Leopold &
Lechner, 2015).
A problem in all studies of health eﬀects of loss of close family
members is that a number of individual and societal factors may
inﬂuence both the chance of such a death and the health of the
individual under study (Boyle, Feng, & Raab, 2011; Van den Berg,
Lindeboom, & Portrait, 2011). To mitigate these problems, the
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German study controlled for unobserved time-invariant individual
characteristics, using a within-individual ﬁxed-eﬀects approach. Also
the two American studies were based on measurements at diﬀerent
times for each person, but used another type of panel approach.
Our goal is to add to the knowledge about how the death of a
mother or father aﬀects adults’ health by taking steps in three
directions. First, we use register data for an entire national population.
These include high-quality objective information on purchases of
prescription medication, which we consider an indicator of health
(although such purchases also reﬂect the use of health care as further
discussed below). The only previous large register-based study (using
Swedish data) focused on death, which is a rare outcome among young
adults. Second, we make a distinction between mental and physical
health responses, which was only done in the two American survey-
based investigations, and we consider a quite long period of 10 years
after a parental death, over which the relative importance of these two
responses may change. We also examine medication use prior to the
death of a parent in order to see if there is any eﬀect which might arise
from caregiving responsibilities and concerns over the parent's health.
The German researchers also considered responses before death but
not the other studies mentioned above. Third, we employ a longitudinal
approach that controls for unobserved factors that have a constant
eﬀect on the health of the individual under study and may be associated
with determinants of the parent's death. Such factors include geneti-
cally linked diseases or disease risks and certain traits and behaviours,
for example health related behaviours and use of healthcare, which are
likely to be similar within families. Furthermore, there is a large
constant component of socioeconomic resources (also inﬂuenced by the
family background and often not quite adequately measured in the
data), which may operate through the mentioned factors as well as
other channels. Constant time-invariant factors were also controlled for
in the German study of eﬀects on subjective well-being, but this
approach could not be used in the Swedish study that, like ours, was
based on national register data, as it was focused on death (which
occurs only once for a person).
Our focus is on eﬀects of parental deaths among adults younger
than 59, as the data did not allow older individuals to be included. We
consider two broad age groups and draw the dividing line at 40 years
(almost in the middle of the 18–59 interval). Women and men are
compared, but, for simplicity, we do not consider other interactive
eﬀects, such as how the responses to a parental death may vary with the
person's own family situation.
2. Theoretical considerations
2.1. How the death of a parent may aﬀect health
There are many reasons why an adult's health may be aﬀected by the
death of a parent. The grief and associated stress (Richardson et al., 2015)
may cause mood and anxiety disorders (often diﬃcult to distinguish from
the intense sadness and anxiety that may be common features of the grief;
Shear, 2012). The stress response, possibly in combination with poorer
mental health, may also have implications for physical health, including
the development and progression of cardiovascular diseases (Hamer,
Endrighi, Venuraju, Lahiri, & Steptoe, 2012; Steptoe & Kivimäki, 2012).
These reactions may compound each other as poorer physical health also
increases the chance of depression and other mental diseases (Kessler &
Bromet, 2013). Additionally, there may be more indirect health inﬂuences
through grief- and stress-induced lifestyle changes, such as more use of
alcohol, intensiﬁed smoking or a lower chance of quitting smoking
(Kassel, Stroud, & Paronis, 2003; Umberson, 2003). Furthermore, many
adults beneﬁt from emotional and instrumental support from parents
(Bengtson, 2001), and loss of this advantage may have adverse health
eﬀects. Also, the death of one parent may lead to increased responsibility
and concern for the surviving spouse if there is one (Umberson, 2003).
In some circumstances these disadvantages may be oﬀset by certain
beneﬁts. For example, caring for a close family member during terminal
illness or earlier, or being very worried, may constitute a substantial
burden on health (Christakis & Allison, 2006; Luhmann, Hofmann, Eid,
& Lucas, 2012; Wolf, Raissian, & Grundy, 2015), and although this
burden may leave a long-term mark (Moriarty, Maguire, O’Reilly, &
McCann, 2015), it is also possible that the death to some extent may be
felt as a relief, so that the person's health improves sometime afterwards
(Rostila & Saarela, 2011). A combination of such a response and some of
the mentioned longer-term disadvantages could, in theory, underlie the
initial decline and subsequent increase in mortality observed by Rostila
and Saarela (2011). Another possible beneﬁcial eﬀect is that bequests
from deceased parents may improve the ﬁnancial status of their children,
with positive health implications (Rostila & Saarela, 2011). Additionally,
experiencing a death in the near family may make people more conscious
about their own health risks, leading to healthier behaviour (Marks et al.,
2007; Umberson & Meichu, 1994). Finally, death may come as a relief if
there has been an extremely diﬃcult relationship with the parent
(Umberson & Meichu, 1994).
Some of these responses may be more immediate than others. For
example, the grief and associated stress reaction may inﬂuence mental
health rather quickly, while it may take some time for physical health to
be aﬀected. Also, to the extent that there are bereavement-induced
changes in lifestyle with implications for physical and perhaps mental
health (through grief or, on the more positive side, inheritance from the
deceased parent or stronger consciousness about own health risks), the
process would likely be rather slow. Some responses may also be more
transitory than others. In particular, eﬀects triggered by a heavy care
burden for a sick parent may wane quite shortly after the death. Besides,
for many bereaved people, the grief and stress may become less intense
after a while (Umberson, 2003), and to the extent that the death leads to
an important loss of support, alternative sources may be found.
Furthermore, if new lifestyle habits are developed as a result of a parent's
death, it may be possible to reverse these. However, it is also possible that
some of these problems are not quickly solved (e.g. inability to substitute
support from parents with other kinds of support), and in the worst case a
vicious circle may develop: One bad health condition may increase the
chance of another, so that the health disadvantage actually increases as
time goes on (as indicated by the studies by Marks et al. (2007) and
Rostila and Saarela (2011)). Thus, it is far from obvious how the eﬀects of
parental loss should be expected to progress over time, except that the
mental response probably comes earlier than the physical.
It is also diﬃcult to predict how eﬀects of maternal and paternal
losses may diﬀer. One possibility is that maternal deaths are felt more
strongly because children, by and large, are more attached to their
mother (Silverstein, Bengtson, & Lawton, 1997; Umberson, 2003).
Two of the earlier studies do indeed point in that direction, but only for
one of these sexes, as further discussed below (Rostila & Saarela,
2011; Leopold & Lechner, 2015).
2.2. Interactive eﬀects
Parental deaths are likely to be particularly harmful to young children,
for obvious reasons. Among adults, dependence on parents and the value
of parental support may weaken as age increases. Indeed, as the parents
themselves also become older, the direction of the net support streammay
change. Furthermore, it is possible that dramatic and completely
unexpected deaths have the most harmful implications (Merlevede
et al., 2004; Rostila & Saarela, 2011), and these are more common at
an early age. Overall, this would suggest that death of a parent has more
adverse eﬀects among younger compared with older, as reported in an
earlier study (Leopold & Lechner, 2015).
Responses to parental deaths may diﬀer also by gender, for example
because of variations in dependence on the deceased, or in vulnerability
and coping strategies. The evidence is very diverse, however. A stronger
eﬀect for men than for women has been suggested in some studies
(Rostila & Saarela, 2011), especially when considering physical health
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(Marks et al., 2007). Sex diﬀerences in this direction are consistent with
an idea that women have other, and perhaps more eﬃcient, coping
strategies and also stronger alternative support networks (Umberson,
2003). However, daughters tend to have more contact with their parents
as adults (Umberson, 2003; Silverstein et al., 1997), which could make
them feel the loss particularly intensely. Daughters are also likely to be
more involved in caregiving (Leopold, Raab & Engelhardt, 2014), which
could work either way. Other studies have shown particularly strong
responses for the child with the same sex as the parent who has died
(Marks et al. 2007), and especially in mother-daughter dyads (Umberson
& Meichu, 1994; Leopold & Lechner 2015), reﬂecting the suggested
uniqueness of this relationship (Silverstein et al., 1997). It has also been
reported that men who lose their mother are most strongly aﬀected
(Rostila & Saarela, 2011).
3. Data and methods
3.1. Data sources
The core data source for this study was the Norwegian Central
Population Register, which includes everyone who has lived in Norway
at any point since 1964. Information about year of birth, death,
immigration and emigration (if any), as well as parent identiﬁers, was
taken from the 2008 version of the register. The study population
included those aged 18–59 in 2004 (i.e. born 1945–1986). Parent
identiﬁers exist for almost everyone born after 1953, but for an increas-
ingly smaller proportion as we go further back in time (see Appendix
Table A1), so it would not be meaningful to include individuals born
before about 1945. The time of death, if any, is known for all parents who
are identiﬁed. Unfortunately, there was no information about the cause of
death in the data available to us.
Information on purchases of prescription medicine was added from
the Norwegian Prescription Database (NorPD; Furu et al., 2010).
NorPD was started in 2004 and records all purchases of prescription
medication - deﬁned by Anatomical Therapeutic Code (ATC) codes - by
all Norwegian residents except the few (in the age group considered in
this study) who live in health care institutions.
3.2. Outcome variables
Several summary measures of morbidity based on administrative data
have been suggested (Yurkovich, Avina-Zubieta, Thomas, Gorenchtein &
Lacaille, 2015). These include medication-based indices, most of which
reﬂect the idea that certain classes of medication can be seen as indicators
of certain diseases or conditions (“diseases” is used below for simplicity),
in the sense that they are used speciﬁcally for these and not for others.
These diseases can then simply be counted (Sarfati, 2012), or one may
construct a severity-weighted summary measure based on professional
judgements of the severity of the diseases (von Korﬀ, Wagner &
Saunders, 1992; Fishman et al., 2003). Alternatively, one may want to
take into account also the medicines that are not uniquely used for certain
diseases, but may still provide information about the person's health. This
may be done, for example, by considering the total number of diﬀerent
medicines purchased (Alibhai et al., 2008; Perkins et al., 2004;
Schneeweiss et al., 2001). Using ATC codes, it would be reasonable to
consider medicines as being diﬀerent if the ﬁrst ﬁve digits of the code
(deﬁning the active substance) are diﬀerent.
This study was based primarily on the total number of diﬀerent
prescription medicines purchased within a year, but we also considered
the total number of diseases within a year, inferred using Kuo et al.’s
(2011) identiﬁcation of 32 diseases treated by drugs uniquely pre-
scribed for these diseases. Furthermore, we constructed another and
original version of the latter variable by giving severity weights to each
disease. These weights were taken as the eﬀects of purchases of the
respective medicines in the preceding year on all-cause mortality,
according to a discrete-time model estimated for persons aged 30–79
(when there are more deaths) in 2005–2008. Thus, if the severity-
weighted medication index is, for example, 0.2 higher for one person
than for another, it means that there is a diﬀerence in overall
medication use associated with a rise of 0.2 in the log-odds of dying
in a general population at age 30–79. Additionally, we considered the
total number of mental diseases and the total number of physical
diseases. The former were depression, anxiety, psychosis and bipolar
disorders, the ﬁrst two of these being clearly the most common.
3.3. Models
The idea is to analyse how the outcome variable, which is deﬁned
for each year between 2004 and 2008 on the basis of purchases of
prescription medicine, depends on whether the parent is dead at that
time and how many years earlier the death took place. In the ﬁrst part
of the analysis, those whose parent was alive were divided into three
groups: parent dead the next year, parent dead the year after that, and
parent survived at least the next two years (in which case the parent
may have died three or more year later or still be alive at the end of
study period in 2008).
To be more speciﬁc, for women and men who were 18–59 years old
in 2004 and for whom the father/mother was identiﬁed in the data, the
following Poisson model was estimated, separately for the two age
groups:
b a b xlog(E(Y ))=b + + + mit 0 1 it 2 it i (1)
E(Yit) is the expectation value of the number of diﬀerent medicines
purchased during year t (between 2004 and 2008) by individual i, and
mi is a person-speciﬁc error term (ﬁxed eﬀect) picking up unobserved
time-invariant factors that may be linked to factors aﬀecting the
father's/mother's chance of dying. xit is a vector of dummies for
father's/mother's “status” at time t. The categories for this variable
were “father/mother alive and not dead within the next two years”
(reference category), “father/mother died two years later”, “father/
mother died one year later”, “father/mother died the same year”,
“father/mother died one year earlier”, “father/mother died two years
earlier”, etc. up to “father/mother died nine years earlier”.
Observations corresponding to the father/mother being dead for 10
or more years were left out.
Thus, individuals whose parent died before 1995 did not contribute
in the analysis. Those whose parent died in 1995 contributed only an
observation for 2004 (parent dead 9 years earlier), while those whose
parent died in 1996 contributed observations for 2004 and 2005
(parent died eight years earlier and nine years earlier, respectively),
and so on. Those whose parent died in 2007 or 2008 contributed
observations in the reference category for 2004 or 2004–2005,
respectively, and in other categories for the remaining years, while
those whose parent was still alive by the end of 2008 contributed
observations in the reference category for all years 2004–2008. Other
individuals did not contribute observations in the reference category.
(Individuals who had not lost their parent by the end of 2008 may, of
course, have lost the parent later. Thus, their observations from 2007
and 2008 could in reality belong in the two categories “parent dead one
year later” or “parent dead two years later”. For that reason, all
observations for 2007 and 2008 for individuals who had not lost their
parent by the end of 2008 were excluded in supplementary estimation.
This gave very similar results.).
ait is a vector of dummies for the individual's age at time t, each
representing a one-year age group. For an individual, a one-year
increase in age goes hand in hand with a one-year later calendar year,
so these age eﬀects also capture the weak secular increase in medica-
tion purchases. It is important to include age in the model, because as
time since death increases the person also becomes older (and later
calendar years are entered), and more medication is purchased because
of that. Age eﬀects are identiﬁed from the one-year observations in the
reference category for the x-variable, for individuals for whom there
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are at least two such observations.
To provide an intuitive understanding of the ﬁxed-eﬀect approach, the
eﬀects of parental death and time since parental death are essentially
estimated by comparing the change in medication purchases as the
individuals “move” across the relevant categories of x (e.g. from “parent
dead next year” to “parent dead same year”, or from “parent dead eight
years ago” to “parent dead nine years ago”) with the change in medication
purchases over the same ages for those remaining in the reference
category.
The reason for using one-year categories for time since a parent's
death is that, if there are broader categories and the outcome variable
really changes with time since death within each of these categories, this
change will contribute to the age eﬀect, which obviously has implications
for the estimates of the duration eﬀects. Preliminary estimation showed
that the eﬀects of long duration since death were considerably diﬀerent if
two- or three-year categories were used rather than one-year categories.
For similar reasons, adding a broad category for 10 or more years could
be potentially problematic, although the other parameter estimates were
actually only moderately changed when this was done.
Obviously, only observations for years between 2004 and 2008 in
which the individual was alive and resident in the country both at the
beginning and end of the year could be included in the analysis.
Mortality is low at the ages considered in the study. For example, in the
total Norwegian population only 1.4% die before age 40 and 5.3%
before age 59, according to the most recent life tables (Statistics
Norway, 2016).
The models were estimated with the xtpoisson procedure in the
Stata software, using the robust option to allow for within-individual
clustering in the calculation of standard errors. Because of concern
about possible overdispersion, some negative binomial models were
also estimated, but the results were almost identical.
To avoid being drowned in parameter estimates when comparing
results across outcomes and when considering the interactions with
sex, we also estimated the simpler model:
b alog (E(Y )) = b + +b d +b d (t−t ) + mit 0 1 it 2 it 3 it 0 i (2)
where dit is 1 if the parent was dead at time t and otherwise 0 (i.e. the
reference group now included also observations one or two years before
death). t0 is the year of death. Such models were estimated for the two
main age groups as well as these groups combined, and for all outcome
variables with one exception: When analysing the disease indicator
based on severity weights, which is a continuous variable, linear models
were estimated by means of the xtreg procedure. log (E(Yit)) was then
substituted by Yit in (2) and an individual-level time-speciﬁc random
term was added.
When considering the modifying impact of the child's sex si
(1=female, 0=male), we also allowed the age eﬀect to diﬀer with sex.
Thus, the model for a categorical outcome was:
b a b alog (E(Y )) = b + + b d + b d (t−t ) + s +b d s +b
d (t−t )s + m
it 0 1 it 2 it 3 it 0 4 it i 5 it i 6
it 0 i i (3)
(The main eﬀect of sex is subsumed in the ﬁxed eﬀect.) When
analysing the severity-weighted disease indicator, log (E(Yit)) was,
again, substituted by Yit and an individual-level time-speciﬁc random
term was added.
Because of the small range of values for some of the outcome
variables (see details below), we also estimated some logistic models.
Focusing on two of the outcomes, we estimated models for the
probability of using at least two (or at least three) diﬀerent medicines,
and for the probability of having at least one mental disease. Besides,
we estimated linear models for these two categorical outcomes. (In
economics, the use of linear models is quite common even when the
outcome variable is dichotomous.) The eﬀects could, of course, not be
expected to have the same absolute value as the eﬀects in the Poisson
models, but the signs were the same (not shown in tables).
In comparison, leaving out the ﬁxed eﬀects gave larger eﬀects of
parental deaths (not shown in tables), as one would expect. Without the
ﬁxed eﬀects one should, of course, instead control for various observed
factors that could be linked to parental deaths as well as aﬀecting the
person's health. For example, adding education reduced the eﬀects,
although they were still higher than according to the ﬁxed-eﬀects
analysis.
3.4. Description of the samples
The proportions of the one-year observations that are in one of the
three “alive” categories (i.e. the reference category or the categories for
parent died one or two years later) are shown in Table 1. For example,
in the analysis of paternal deaths within the age group 40–59 (and
where observations 10 or more years after the paternal death were left
out, as explained earlier), 55 percent were in this category. In the
analysis of maternal deaths, the corresponding proportion was 70
percent, reﬂecting women's higher life expectancy. The corresponding
Table 1
Effects (with standard errors) of parental deaths on the number of different medicines
purchased within a year, among women and men aged 18–59.
Loss of
mother
Loss of
mother
Loss of
father
Loss of
father
18-39 40-59 18-39 40-59
Alive and not dead
within next two
years
0 0 0 0
Dead 2 years
later 0.0184**
(0.0080)
0.0008
(0.0031)
0.0085
(0.0060)
0.0023
(0.0036)
Dead 1 year
later 0.0322**
(0.0084)
0.0005
(0.0033)
0.0220**
(0.0062)
0.0057
(0.0037)
Dead same
year 0.0437**
(0.0087)
0.0074*
(0.0034)
0.0328**
(0.0064)
0.0159**
(0.0039)
Dead
1 year earlier 0.0334**
(0.0094)
0.0126**
(0.0038)
0.0372**
(0.0070)
0.0182**
(0.0043)
2 years earlier 0.0304**
(0.0102)
0.0071
(0.0042)
0.0416**
(0.0076)
0.0174**
(0.0048)
3 years earlier 0.0285*
(0.0110)
0.0114*
(0.0045)
0.0417**
(0.0082)
0.0152**
(0.0052)
4 years earlier 0.0216
(0.0118)
0.0123*
(0.0049)
0.0396**
(0.0088)
0.0164**
(0.0057)
5 years earlier 0.0349**
(0.0126)
0.0112*
(0.0052)
0.0395**
(0.0094)
0.0174**
(0.0061)
6 years earlier 0.0374**
(0.0133)
0.0149**
(0.0056)
0.0518**
(0.0100)
0.0227**
(0.0063)
7 years earlier 0.0389**
(0.0142)
0.0173**
(0.0060)
0.0649**
(0.0105)
0.0233**
(0.0070)
8 years earlier 0.0419**
(0.0151)
0.0209**
(0.0064)
0.0657**
(0.0111)
0.0206**
(0.0074)
9 years earlier 0.0387*
(0.0160)
0.0220**
(0.0068)
0.0721**
(0.0117)
0.0288**
(0.0079)
Number of
observations
(millions)
6.08 4.25 5.78 3.04
Proportion (%) of
observations in
“alive” categories
95.8 70.0 91.2 54.6
Notes: Each column shows estimates from one model, which also includes age in one-
year categories and individual fixed effects.
* p < 0.05.
** p < 0.01.
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proportions were, of course, higher in the younger age group 18–39.
These ﬁgures accord reasonably well with some simple cross-
sectional calculations for Norwegian residents in 2008: Among in-
dividuals aged 40–44 (the ﬁrst ﬁve years of the oldest age group in our
statistical analysis), 13% had lost a mother and 29% had lost a father,
although many of those deaths could have taken place more than 10
years earlier (see Appendix Table A1, which shows results from
calculations based on the same register data as used for the statistical
analysis). The corresponding numbers for the age group 55–59 (the
last ﬁve years of the oldest age group considered in the analysis) were
54% and 81%.
Individuals aged 18–39 on average purchased 2.1 diﬀerent medi-
cines per year during the study period. The standard deviation was 2.5.
The corresponding average was 3.0 in the age group 40–59, and the
standard deviation was 3.4. In the latter age group, 26% purchased no
medicines, 17% purchased one, 14% purchased two, 11% purchased
three, 9% purchased four, and 24% purchased ﬁve or more (of which
only 5% purchased more than nine). The averages were 88% and 45%
higher among women than men in the two age groups. Averages and
standard deviations of all outcome variables are shown in Table 2. The
lowest average, for mental diseases at age 18–39, is 0.11. (92% had no
such disease as judged from the medication purchases, 6% had one and
2% had two or more.).
4. Results
4.1. Number of diﬀerent medicines
Individuals of age 18–39 years who had lost their father the same
year had somewhat poorer health than those with a father who was
alive and not dying within the next two years (the reference category),
as judged from the 3.3% higher number of diﬀerent medicines
purchased (Table 1). The number 3.3 is calculated by exponentiating
the parameter estimate 0.0328 and subtracting 1. More medicine was
also purchased in the year preceding the father's death, but not as
much as in the year of the death itself. Over the subsequent 10 years,
the eﬀect of having lost a father ﬁrst increased slowly and then more
rapidly, reaching 7.5% higher number of medication purchases
(=exp(0.0721)-1). For those losing their mother at this age, the
increase in medication purchases around the time of death was
somewhat higher according to the point estimates (but conﬁdence
intervals were overlapping), followed by a decline and subsequent
increase to almost the same level. Among those losing a parent at age
40–59, there was no clear upturn in the medication purchases before
death. In the year of the parental death, there were only 0.7%-1.6%
more purchases than in the reference category (and also a weaker
response than at age 18–39 in absolute terms), but this was followed by
an increase up to more than 2% over the 10-year period. On the whole,
there was not a consistent diﬀerence in the 10-year increase between
the two age groups.
Turning to the simpler models and pooling the two age groups, the
Table 2
Average and standard deviation of outcome variables in the sample used to analyse
effects of paternal deaths.
Age 18–39 Age 40–59
Average Standard
deviation
Average Standard
deviation
Total number of
diﬀerent medicines
2.09 2.54 2.99 3.36
Total number of
diseases, severity
weighted
0.10 0.39 0.19 0.54
Total number of
diseases
0.57 0.98 1.09 1.47
Total number of mental
diseases
0.11 0.39 0.18 0.50
Total number of
diseases, except
mental
0.46 0.82 0.91 1.27
Table 3
Effects (with standard errors) of parental deaths on various medication-based health
indicators, among women and men aged 18–59.
Total
number of
different
medicines
Total
number of
diseases,
severity
weighted
Total
number of
diseases
Total
number of
mental
diseases
Total
number of
diseases,
except
mental
Loss of
mo-
ther
Age 18–
59
Dead 0.0089**
(0.0019)
0.0079**
(0.0012)
0.0089**
(0.0022)
0.0641**
(0.0047)
-0.0011
(0.0024)
Year
since
death
0.0012*
(0.0006)
0.0010**
(0.0004)
0.0000
(0.0007)
−0.0123**
(0.0014)
0.0028**
(0.0007)
Age 18–
39
Dead 0.0172**
(0.0052)
0.0102**
(0.0023)
0.0144*
(0.0070)
0.1179**
(0.0137)
−0.0139
(0.0078)
Year
since
death
−0.0006
(0.0015)
0.0005
(0.0007)
−0.0048*
(0.0020)
−0.0324**
(0.0040)
0.0032
(0.0021)
Age 40–
59
Dead 0.0075**
(0.0020)
0.0073**
(0.0014)
0.0085**
(0.0023)
0.0561**
(0.0050)
0.0005
(0.0025)
Year
since
death
0.0014*
(0.0006)
0.0011**
(0.0004)
0.0006
(0.0007)
−0.0087**
(0.0015)
0.0028**
(0.0007)
Loss of
fa-
ther
Age 18–
59
Dead 0.0147**
(0.0020)
0.0073**
(0.0011)
0.0142**
(0.0024)
0.0538**
(0.0051)
0.0063*
(0.0026)
Year
since
death
0.0019**
(0.0005)
0.0005
(0.0003)
−0.0007
(0.0007)
−0.0114**
(0.0015)
0.0018*
(0.0008)
Age 18–
39
Dead 0.0195**
(0.0039)
0.0085**
(0.0017)
0.0232**
(0.0053)
0.0829**
(0.0106)
0.0079
(0.0058)
Year
since
death
0.0038**
(0.0011)
0.0008
(0.0005)
−0.0012
(0.0015)
−0.0189**
(0.0030)
0.0034*
(0.0015)
Age 40–
59
Dead 0.0121**
(0.0023)
0.0065**
(0.0014)
0.0115**
(0.0026)
0.0446**
(0.0057)
0.0053
(0.0029)
Year
since
death
0.0009
(0.0007)
0.0002
(0.0004)
−0.0007
(0.0008)
−0.0089**
(0.0017)
0.0012
(0.0009)
Notes: For each outcome variable and age group, each model includes whether the parent
under consideration is dead (alive is reference category) and the time since death. Effects
of these two variables are shown in the table. The models also include the person's age in
one-year categories and individual fixed effects.
*p < 0.05.
** p <0.01.
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additional medication purchases associated with a mother's death
increased by 0.12% annually over the subsequent 10 years (the
parameter estimate being 0.0012; Table 3, ﬁrst column), while the
corresponding increase after a father's death was 0.19%. However,
conﬁdence intervals overlap, so one cannot conclude that eﬀects of
paternal and maternal deaths are diﬀerent (and not from the results for
other outcomes either; see below). In comparison, medication pur-
chases increased by 4.0% annually in the general population (not
shown in the tables). Stated diﬀerently, when a person who has not lost
a parent becomes one year older (and a new calendar year is entered),
he or she purchases 4.0% more medicines. A person who has lost a
mother or father purchases generally more medicine as a result of that
loss, and the annual increase after that is not 4.0%, but 4.12% or
4.19%, respectively. Thus, one could say that those who have lost a
parent have experienced a subsequent deterioration of health over age
that is between 3% (0.12/4.0) and 5% (0.19/4.0) stronger than among
other people (i.e., 4% overall, to make it simpler). Anyway, regardless
of the perspective that is taken, the immediate response and subse-
quent further deterioration must be considered as rather weak.
4.2. Other medication-based outcome variables
Table 3 shows estimates also from models for the other medication-
based indicators. An immediate adverse response appeared also when
the total number of diseases, calculated with or without severity
weights, was considered as an alternative indicator of the general
health. Moreover, the disadvantage increased over time after maternal
deaths in the age group 40–59 and the entire age group 18–59 when
the severity weights were taken into account. (It is an absolute increase
that is considered in these particular models, but predictions showed
that there was also an increase in relative terms, such as considered in
the other models.) There was an opposite trend after maternal deaths
at age 18–39 when the severity weights were not taken into account.
Even more interestingly, when the sum of diseases was split into
mental and other diseases, we observed an immediate increase of 4–
13% in the use of medication for the former after a parental death
(most sharply in the youngest age group) and some evidence of an
increase with respect to the latter (only signiﬁcant at 5% level after
paternal deaths and when considering the entire age group 18–59).
Moreover, there was a decline in the excess use of medicines for mental
diseases over the subsequent 10 years, while there was an increase in
the excess use of medicines for other diseases after maternal deaths in
the age group 40–59 and after paternal deaths in the age group 18–39.
In other words, the increase observed in the models for the total
number of diﬀerent medicines seems to be exclusively due to an
increasing excess use of medication for other diseases than the mental.
4.3. Sex diﬀerences
Because of the modest variation across age that appeared in the
other analysis, observations for both main age groups were used when
analysing sex diﬀerences. According to the models for the total number
of diﬀerent medicines purchased, daughters only had about half as
sharp immediate response to a father's death as did the sons (Table 4).
(Also the absolute eﬀect was somewhat weaker among women, who use
more medicine than men, but not twice as many.) There were
indications in the same direction with respect to maternal deaths (p
<0.10). However, the subsequent increase after paternal deaths was
restricted to the daughters. The point estimates suggest the same
pattern after maternal deaths.
Also the total number of diseases increased more for daughters than
for sons over the 10 years after a father's death. The particularly sharp
increase in the disadvantage for daughters seems to be entirely a result
of a physical health response that needs more time to build up for them
(starting at a lower level but increasing more afterwards).
5. Discussion
This analysis showed that the loss of a parent has adverse health
eﬀects, as judged by the purchase of prescription medicine (which
probably is a very good measure of the use). In addition to an
immediate response, which was largest among the youngest, the excess
use of medication increased among bereaved oﬀspring with increasing
time since the death in some situations (loss of mother at age 40–59
and loss of father at age 18–39). Taking the estimates for both age
groups into account – and considering also the other outcome variables
- it is impossible to conclude whether the response to a mother's death
is diﬀerent from the response to a father's death.
The eﬀects of parents' death were rather small, however. The
number of diﬀerent medicines that was purchased increased by only
1–4% around the time of death, and over the subsequent 10 years the
annual increase in the medication purchases was, on the whole, about
0.15 percentage points larger (and thus 4% larger in relative terms)
than in the general population.
These results imply that the potential beneﬁcial eﬀects of a parental
death, such as a stronger consciousness about own health risks and
economic improvement because of inheritance, are more than out-
balanced by various disadvantages. As mentioned, these disadvantages
include loss of support and grief-induced stress (operating partly
through life style changes), which may have implications both for
physical and mental health. Additionally, the health could be relatively
poor when the burden of care and worries is most intense shortly
before death, and this may leave a mark on health for some time after
death. In support of that idea, there were indications of relatively poor
health during the one or two years before death, although only among
the youngest. While deaths of relatively young parents are often
unexpected and not preceded by a long illness period, there is also a
Table 4
Sex-specific effects (with standard errors) of parental deaths on various medication-
based health indicators, among women and men aged 18–59.
Total
number of
different
medicines
Total
number
of
diseases,
severity
weighted
Total
number
of
diseases
Total
number of
mental
diseases
Total
number of
diseases,
except
mental
Loss of mother, age 18–59
Dead 0.0128**
(0.0030)
0.0072**
(0.0015)
0.0115**
(0.0032)
0.0677**
(0.0081)
0.0036
(0.0034)
Year 0.0000
(0.0009)
0.0015**
(0.0005)
−0.0005
(0.0010)
−0.0099**
(0.0024)
0.0013
(0.0010)
Dead×Female −0.0068
(0.0039)
0.0014
(0.0024)
−0.0048
(0.0044)
−0.0056
(0.0099)
−0.0096*
(0.0048)
Year since
dead×Femal-
e
0.0018
(0.0011)
−0.0010
(0.0007)
0.0009
(0.0013)
−0.0039
(0.0029)
0.0029*
(0.0014)
Loss of father, age 18–59
Dead 0.0201**
(0.0022)
0.0057**
(0.0014)
0.0175**
(0.0036)
0.0478**
(0.0084)
0.0127**
(0.0038)
Year 0.0002
(0.0009)
0.0006
(0.0004)
−0.0022*
(0.0010)
−0.0109**
(0.0024)
−0.0006
(0.0011)
Dead×Female −0.0093**
(0.0041)
0.0033
(0.0021)
−0.0063
(0.0048)
0.0099
(0.0106)
−0.0128*
(0.0052)
Year since
dead×Femal-
e
0.0027**
(0.0012)
−0.0003
(0.0006)
0.0028*
(0.0014)
−0.0008
(0.0031)
0.0046**
(0.0015)
Notes: For each outcome variable, each model includes whether the parent under
consideration is dead (alive is reference category), the time since death and interactions
between these variables and the person's sex (Female=1 if individual is female, otherwise
0). Effects of these four variables are shown in the table. The models also include the
person's age in one-year categories and individual fixed effects.
* p < 0.05.
**p < 0.01.
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large proportion of the other early deaths that are a result of cancer,
which to a particular extent may involve some years with great
concerns over the person's health. Besides, it is possible that the
youngest are generally more upset about any potentially fatal disease
among parents because of the stronger dependence on the parents that
was mentioned as a possible reason for their sharper reaction to a
death.
As mentioned earlier, some types of response may come quickly,
while others may need some time to build up. Furthermore, some may
be transitory, while others are long-lasting or even accumulative.
Predicting the overall outcome would be very diﬃcult, but it seems at
least likely that the impact on the mental health is more immediate
than that on the physical health. In line with that idea, our analysis
showed that the mental response was sharper than the physical shortly
after death, but that the former became weaker over time, whereas the
latter became stronger. However, it is far from obvious that one should
expect a steadily accumulating disadvantage with respect to the
physical health such as indicated by some observed increases in the
excess total use of medication throughout the 10-year period under
study.
Adverse health eﬀects were seen also in the two American studies of
parents' death (Marks et al., 2007; Umberson & Meichu, 1994), and
one of them indicated a particularly strong worsening of the health
situation over a ﬁve-year period for those who had lost their parents
some time before this period (Marks et al., 2007). This accords with the
increasing disadvantage we found. Also the results from the Swedish
study of mortality bears some resemblance with ours, although there
are also clear diﬀerences, as the authors reported a temporarily lower
mortality after a parent's death, followed by an increase (Rostila &
Saarela, 2011). However, the more careful analysis of the temporal
pattern in the German study (Leopold & Lechner, 2015) did not reveal
any lasting disadvantage, except in one case, but rather a short-term
worsening of subjective well-being. In other words, the pattern that we
have observed with our presumably good data and control for
unobserved time-invariant factors – and that is by no means theore-
tically implausible (see earlier discussion of a possible vicious circle) –
is quite diﬀerent from what has been reported in the literature. There
are no obvious reasons why an increasing disadvantage should appear
only in a Norwegian setting, so a similar trend might appear also in
other countries if the same kind of data and method were used.
Some earlier studies have suggested sharper eﬀects of parental
deaths at lower ages, but such a pattern was only moderately supported
by our analysis. While the immediate response was sharpest at the
youngest ages, and only the youngest had increased use of medication
already before the parent's death, the subsequent medication trajec-
tories did not vary consistently with age.
The existing evidence is quite mixed when it comes to the sex
diﬀerences. In our analysis, the models for total number of diﬀerent
medicines showed a particularly strong immediate response among
men after a parental death (one eﬀect being signiﬁcant and the other
almost signiﬁcant). However, the subsequent increase appeared to be
restricted to daughters. This pattern seemed to be entirely due to a
slower physical reaction to parental loss among women. Thus, there
was no basis, on the whole, for concluding that daughters and sons
were diﬀerentially aﬀected by parental deaths, and no trace of a
particularly sharp response to maternal deaths among daughters, as
argued by some researchers.
5.1. Weaknesses
Estimates may be biased by selection even with this ﬁxed-eﬀects
approach, as it only takes into account that certain unobserved factors
of importance for a parent's mortality have a constant eﬀect on the
person's health. The higher usage of medication after a parent's death
that is indicated by many of our estimates could, in theory, be the result
of time-varying confounding factors. For example, acute dramatic
family circumstances may have led to this death and also inﬂuence the
health of the person under study negatively around the time of death
and later.
Moreover, the increasing disadvantage after death could partly or
fully be the result of childhood adversity or other factors that are linked
to high parental mortality and also create an accumulative health
disadvantage for the son or daughter. In other words, he or she may
have been on a relatively steep upward trend in medication use already
before the death, and might have remained on that path had the parent
not died (yet). The education of the adult under study may capture
some of this adversity, and we therefore added interactions between
three educational categories and age in some supplementary models for
those aged 40–59 (among whom a parental death up to 10 years earlier
is not likely to have had any impact on the educational career). With
such a model that allows for educational diﬀerences in the “basic age
trend”, the increase in the excess medication use after mother's or
father's death was reduced by only about 8% (not shown). It remains to
be known, of course, whether unobserved indicators of earlier adversity
could have explained more of the increase.
Another weakness of the analysis is that it only includes the use of
prescription medicine, not other types of medicine, which also reﬂect
the health situation. Besides, the use of prescription medicine is not
only a result of sickness and need for medicines, but also the use of
health care services. Health care usage is partly a result of attitudes,
which to some extent are constant and therefore controlled for.
However, there is also likely to be variation in health care usage over
time, and even a variation that is linked to parental death. To be more
speciﬁc, relatives of a terminally ill parent may have been in more
contact with health institutions than they otherwise would have been,
which could increase their medication usage around the time of death.
It could also continue to be high after the death if it is common to
renew prescriptions even when the need is no longer so strong.
Alternatively, there may instead be an underuse of medication shortly
before a parent's death because there is not suﬃcient time to take care
of one's own medical needs. One could always speculate whether the
ﬁrst-mentioned mechanism might be the stronger and contribute
substantially to the observed increase in medication purchases shortly
before and after a parent's death. However, it is hard to see how the
widening excess medication purchases over the subsequent years could
be explained by increasing use of health care.
5.2. Conclusion
To conclude, a parent's death has immediate adverse health
consequences, as judged from the purchases of prescription medicines.
Moreover, some results suggested a growing disadvantage among those
who had lost a parent. These eﬀects of parental deaths were generally
rather weak, however. A parental loss aﬀected the use of medication for
mental conditions immediately, and there were indications of a
physical response as well. While the mental response to parental loss
weakened, the physical response became gradually stronger. Gaining
further understanding of this apparently increasing disadvantage in
physical health could be a goal for future research.
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Table A1
Proportion having mother or father alive among women and men born in Norway and alive and residents in Norway 1 January 2008, by age.
Age Number of
individuals
Proportion (%) with at least one parent not
identified
Proportion (%) with at least one parent
emigrated
Proportions (%) among the remaining
Both Mother Father Both
alive dead dead dead
18–19 116188 0.9 1.1 96.6 1.0 2.3 0.1
20–24 254331 0.8 1.4 95.1 1.4 3.4 0.1
25–29 241617 0.8 1.6 92.1 2.3 5.3 0.3
30–34 256280 0.8 1.7 87.3 3.5 8.6 0.7
35–39 302207 0.9 1.8 78.3 5.1 14.6 2.0
40–44 305835 1.1 1.8 63.4 7.0 23.8 5.8
45–49 284371 1.5 1.3 44.8 8.3 32.7 14.3
50–54 282536 2.3 0.7 26.8 8.2 36.9 28.1
55–59 270081 12.5 0.3 12.3 6.5 33.7 47.5
Ø. Kravdal, E. Grundy SSM - Population Health 2 (2016) 868–875
875
